Home » Stocks » Precipio

Precipio, Inc. (PRPO)

Stock Price: $3.20 USD 0.13 (4.23%)
Updated Aug 13, 2020 4:00 PM EDT - Market closed
After-hours: $3.24 +0.04 (1.25%) Aug 13, 7:59 PM

Stock Price Chart

Key Info

Market Cap 46.77M
Revenue (ttm) 3.63M
Net Income (ttm) -14.80M
Shares Out 14.62M
EPS (ttm) -2.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 13, 2020
Last Price $3.20
Previous Close $3.07
Change ($) 0.13
Change (%) 4.23%
Day's Open 3.06
Day's Range 2.96 - 3.36
Day's Volume 2,302,360
52-Week Range 0.55 - 8.00

More Stats

Market Cap 46.77M
Enterprise Value 49.65M
Earnings Date (est) Aug 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 14.62M
Float 10.98M
EPS (basic) -2.62
EPS (diluted) -2.62
FCF / Share -1.07
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 983,680
Short Ratio 0.15
Short % of Float 6.64%
Beta 3.60
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 12.89
PB Ratio 4.48
Revenue 3.63M
Operating Income -11.14M
Net Income -14.80M
Free Cash Flow -8.93M
Net Cash -2.87M
Net Cash / Share -0.20
Gross Margin 6.03%
Operating Margin -306.83%
Profit Margin -499.70%
FCF Margin -245.92%
ROA -29.37%
ROE -140.13%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$2.00*
Low
2.00
Current: $3.20
High
2.00
Target: 2.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3.132.861.722.691.931.2427.5431.4831.9720.05
Revenue Growth9.18%66.22%-36.02%39.61%55.56%-95.5%-12.5%-1.54%59.47%-
Gross Profit0.220.230.291.72-0.01-0.9410.7513.1318.449.76
Operating Income-10.99-13.91-15.51-0.74-8.92-10.57-15.76-9.50-2.97-3.61
Net Income-13.24-15.69-20.69-2.23-32.95-13.94-15.99-8.33-9.78-3.13
Shares Outstanding5.701.440.310.030.030.020.020.010.010.01
Earnings Per Share-2.33-13.82-107.40-141.59-1,251.06-904.55-1,035.05-697.54-1,179.06-324.03
Operating Cash Flow-9.14-6.75-6.69-0.96-12.38-13.70-8.47-10.200.22-1.72
Capital Expenditures-0.06-0.10-0.14--0.20-0.13-0.61-0.88-0.23-0.19
Free Cash Flow-9.20-6.85-6.83-0.96-12.58-13.83-9.08-11.09-0.01-1.91
Cash & Equivalents0.850.380.420.050.441.611.634.504.953.45
Total Debt1.365.113.585.437.607.846.566.1711.729.80
Net Cash / Debt-0.51-4.72-3.16-5.38-7.15-6.23-4.93-1.67-6.78-6.35
Assets19.5121.6127.260.844.8230.0130.2838.7933.5632.03
Liabilities6.3115.4814.247.3017.6423.4518.8318.5222.5122.07
Book Value13.216.1213.03-6.46-12.826.5511.4520.2711.058.50
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Precipio, Inc.
Country United States
Employees 50
CEO Ilan Danieli

Stock Information

Ticker Symbol PRPO
Stock Exchange NASDAQ
Unique Identifier NASDAQ: PRPO

Description

Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; and HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test. It serves oncologists, hospitals, reference laboratories, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine and Harvard's Dana-Farber Cancer Institute. The company is based in New Haven, Connecticut.